Who Owns Marker Therapeutics Stock?
NASDAQ: MRKRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 23.80%
- Held by insiders
- 5.49%
- Institutional holders
- 35
- Institutions 23.8%
- Insiders 5.5%
- Public and other 70.7%
Who owns Marker Therapeutics stock?
Institutional investors own about 23.8% of Marker Therapeutics's shares, spread across 35 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 5.49% of MRKR.
The largest institutional holders are NEA Management Company, LLC (9.75%), Blue Owl Capital Holdings LP (3.32%) and Vanguard Capital Management LLC (2.56%). Together, the top 10 institutions control 22.0% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their MRKR positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of MRKR
| Institution | Shares | % Held | Change |
|---|---|---|---|
| NEA Management Company, LLC | 1.63M | 9.75% | 0.0% |
| Blue Owl Capital Holdings LP | 554.25K | 3.32% | 0.0% |
| Vanguard Capital Management LLC | 426.17K | 2.56% | +9.5% |
| Aisling Capital Management LP | 325.37K | 1.95% | 0.0% |
| Renaissance Technologies, LLC | 249.42K | 1.50% | +42.3% |
| Geode Capital Management, LLC | 139.82K | 0.84% | -13.1% |
| Osaic Holdings Inc. | 112.65K | 0.68% | +21.0% |
| Vanguard Fiduciary Trust Co | 87.27K | 0.52% | 0.0% |
| LPL Financial LLC | 83.15K | 0.50% | +0.1% |
| Concurrent Investment Advisors, LLC | 67.96K | 0.41% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of MRKR
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 298.09K | 1.79% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 128.08K | 0.77% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 72.01K | 0.43% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 19.39K | 0.12% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 12.81K | 0.08% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 3.60K | 0.02% |
Frequently asked questions
Who is the largest shareholder of Marker Therapeutics?
NEA Management Company, LLC is the largest institutional shareholder of MRKR, owning 9.75% of shares outstanding (1.63M shares) as of its latest 13F filing.
What percentage of Marker Therapeutics is owned by institutions?
Institutions own about 23.8% of MRKR shares and 25.2% of the public float.
How much of Marker Therapeutics do insiders own?
Insiders, such as officers and directors, own about 5.49% of MRKR shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.